Summary by Moomoo AI
The latest monthly report on securities changes submitted by Keji Pharmaceutical Group-B (02171.HK) on July 31, 2024 showed that the company did not increase or decrease its statutory/registered capital in July, with a remaining balance of $50,000. However, the issued shares have undergone changes. The company decreased 4,135,500 common shares in July, resulting in the total number of issued shares decreasing from 575,675,415 shares to 571,539,915 shares by the end of the month. The reduction was mainly due to the company purchasing and cancelling the corresponding number of shares on July 29. In addition, as of July 31, 2019, according to the stock-based incentive plan, the number of new shares that may be issued is 3,766,992. The report was submitted by executive director Li Zonghai on August 6, 2024.